These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6573990)

  • 1. Muscle accumulation of Tc-99m diphosphonate in myophosphorylase deficiency and other disorders of muscle glycogenolysis/glycolysis.
    Brumback RA
    Clin Nucl Med; 1983 Apr; 8(4):165-6. PubMed ID: 6573990
    [No Abstract]   [Full Text] [Related]  

  • 2. Tc-99m pyrophosphate muscle labeling in McArdle syndrome.
    Swift TR; Brown M
    J Nucl Med; 1978 Mar; 19(3):295-7. PubMed ID: 204756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. McArdle's disease: a study on the molecular basis of two different etiologies of myophosphorylase deficiency.
    Koster JF; Slee RG; Jennekens FG; Wintzen AR; van Berkel TJ
    Clin Chim Acta; 1979 Jun; 94(3):229-35. PubMed ID: 111879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
    Brooke MH; Patterson VH; Kaiser KK
    Muscle Nerve; 1983; 6(3):204-6. PubMed ID: 6574314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset myophosphorylase deficiency (Mc Ardle's disease) with absence of myophosphorylase protein on SDS electrophoresis. The role of the ischemic forearm test.
    van Riet W; de Meirsman J; de Saedeleer J; Dom R; Carton H; van den Heede J; Bulcke JA
    Clin Neurol Neurosurg; 1985; 87(2):85-90. PubMed ID: 3861283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myophosphorylase deficiency impairs muscle oxidative metabolism.
    Haller RG; Lewis SF; Cook JD; Blomqvist CG
    Ann Neurol; 1985 Feb; 17(2):196-9. PubMed ID: 3856415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital myopathy due to phosphorylase deficiency.
    Cornelio F; Bresolin N; DiMauro S; Mora M; Balestrini MR
    Neurology; 1983 Oct; 33(10):1383-5. PubMed ID: 6577313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic accumulation of technetium 99m-methylene diphosphonate.
    Nisbet AP; Maisey MN
    Br J Radiol; 1982 Jun; 55(654):454-5. PubMed ID: 6213282
    [No Abstract]   [Full Text] [Related]  

  • 9. Accumulation of Tc-99m diphosphonate in pericardial effusion.
    Yeh EL; Thompson MA; Meade RC
    J Nucl Med; 1979 Oct; 20(10):1102-3. PubMed ID: 536768
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glycogen storage disease associated with glycogen deposition in skeletal and heart muscles with low muscle phosphorylase activity].
    Uchida T; Kodama A; Takezawa M; Kijima M; Miyazaki Y; Yui T; Ono K; Ohwada K; Kariyone S
    Nihon Naika Gakkai Zasshi; 1985 Jul; 74(7):945-51. PubMed ID: 3863867
    [No Abstract]   [Full Text] [Related]  

  • 11. [McArdle's disease. Apropos of a case].
    Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J
    Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new variant of late-onset myophosphorylase deficiency.
    Kost GJ; Verity MA
    Muscle Nerve; 1980; 3(3):195-201. PubMed ID: 6929403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
    Daegelen D; Munnich A; Levin MJ; Girault A; Goasguen J; Kahn A; Dreyfus JC
    Ann Hum Genet; 1983 May; 47(2):107-15. PubMed ID: 6576726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphic demonstration of a iatrogenic rhabdomyolysis in McArdle's syndrome (author's transl)].
    Neumann P; Rumpf KW; Kaiser H; Meinck HM; Goebel HH; Schicha H; Emrich D
    Nuklearmedizin; 1982 Feb; 21(1):12-5. PubMed ID: 6210883
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of diffusely increased 99mTc phosphonate compounds uptake in both kidneys].
    Tonami N; Koizumi K; Hisada K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Jun; 42(6):576-81. PubMed ID: 7145618
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic uptake of technetium-99m diphosphonate in thalassemia major.
    Levy HM; Smith R
    Clin Nucl Med; 1986 Feb; 11(2):110-2. PubMed ID: 3769335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disappearance of soft tissue 99mTc diphosphonate activity following radiation therapy.
    Hill LT
    J Natl Med Assoc; 1981 Dec; 73(12):1119-21. PubMed ID: 7328686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glycogenosis type V of adults: muscle phosphorylase deficiency].
    Coll Cantí J; Illa I; Beleta J; Anglada A; Pradas J; González Sastre F; Grau Veciana JM; Gella FJ
    Med Clin (Barc); 1986 Mar; 86(8):335-8. PubMed ID: 3458989
    [No Abstract]   [Full Text] [Related]  

  • 20. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.